XML 19 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Preferred stock, beginning balance (in shares) at Dec. 31, 2021   6,666        
Common stock, beginning balance (in shares) at Dec. 31, 2021     27,957,223      
Balance at beginning of period at Dec. 31, 2021 $ 105,726   $ 28 $ 584,613 $ (478,698) $ (217)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Unrealized gain (loss) on marketable securities (57)         (57)
Foreign currency translation adjustment (166)         (166)
Stock option exercises (in shares)     35,478      
Stock option exercises 66     66    
Stock-based compensation (in shares)     192,138      
Stock-based compensation 3,028     3,028    
Employee stock purchase plan shares issued (in shares)     94,226      
Employee stock purchase plan shares issued 182     182    
Net loss (40,017)       (40,017)  
Preferred stock, ending balance (in shares) at Mar. 31, 2022   6,666        
Common stock, ending balance (in shares) at Mar. 31, 2022     28,279,065      
Balance at end of period at Mar. 31, 2022 $ 68,762   $ 28 587,889 (518,715) (440)
Preferred stock, beginning balance (in shares) at Dec. 31, 2022 6,666 6,666        
Common stock, beginning balance (in shares) at Dec. 31, 2022 28,554,656   28,554,656      
Balance at beginning of period at Dec. 31, 2022 $ 75,019   $ 29 594,173 (518,314) (869)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Unrealized gain (loss) on marketable securities 12         12
Foreign currency translation adjustment $ 59         59
Stock option exercises (in shares) 3,218   3,218      
Stock option exercises $ 4     4    
Stock-based compensation (in shares)     336,206      
Stock-based compensation 1,687     1,687    
Employee stock purchase plan shares issued (in shares)     0      
Net loss $ (16,315)       (16,315)  
Preferred stock, ending balance (in shares) at Mar. 31, 2023 6,666 6,666        
Common stock, ending balance (in shares) at Mar. 31, 2023 28,894,080   28,894,080      
Balance at end of period at Mar. 31, 2023 $ 60,466   $ 29 $ 595,864 $ (534,629) $ (798)